Aldar S. Bourinbaiar
Peace Avenue 25
Ulan Bator, Mongolia
Ulan Bator, Mongolia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month.
Journal: Journal of clinical tuberculosis and other mycobacterial diseases
Published: January 01, 2020
Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L.
Journal: Journal of hepatocellular carcinoma
Published: April 27, 2017
Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis.
Journal: Immunotherapy
Published: November 22, 2016
Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7).
Journal: Immunotherapy
Published: October 04, 2013
Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7).
Journal: Human vaccines & immunotherapeutics
Published: June 21, 2013
Clinical validation of sublingual formulations of Immunoxel (Dzherelo) as an adjuvant immunotherapy in treatment of TB patients.
Journal: Immunotherapy
Published: March 10, 2012
Immune approaches in tuberculosis therapy: a brief overview.
Journal: Expert review of anti-infective therapy
Published: March 09, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026